EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Salicylic acids and pathogenic bacteria: new perspectives on an old compound

Ellen M E Sykes iD, Dawn White, Sydney McLaughlin, Ayush Kumar iD

Canadian Journal of Microbiology · 01.01.2024 · 70 (1) · 1-14

DOI: 10.1139/cjm-2023-0123 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Canadian Journal of Microbiology, erschienen am 01.01.2024. Verfasst von Ellen M E Sykes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, University of Manitoba, Winnipeg, MB, Canada. Hauptthemen laut MEDLINE: Escherichia coli Proteins, Anti-Infective Agents. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 95 Literaturangaben. Gefördert von: Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Salicylic acids have been used in human and veterinary medicine for their anti-pyretic, anti-inflammatory, and analgesic properties for centuries. A key role of salicylic acid—immune modulation in response to microbial infection—was first recognized during studies of their botanical origin. The effects of salicylic acid on bacterial physiology are diverse. In many cases, they impose selective pressures leading to development of cross-resistance to antimicrobial compounds. Initial characterization of these interactions was in Escherichia coli, where salicylic acid activates the multiple antibiotic resistance ( mar) operon, resulting in decreased antibiotic susceptibility. Studies suggest that stimulation of the mar phenotype presents similarly in closely related Enterobacteriaceae. Salicylic acids also affect virulence in many opportunistic pathogens by decreasing their ability to form biofilms and increasing persister cell populations. It is imperative to understand the effects of salicylic acid on bacteria of various origins to illuminate potential links between environmental microbes and their clinically relevant antimicrobial-resistant counterparts. This review provides an update on known effects of salicylic acid and key derivatives on a variety of bacterial pathogens, offers insights to possible potentiation of current treatment options, and highlights cellular regulatory networks that have been established during the study of this important class of medicines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coli ProteinsAnti-Infective AgentsHumansBacterial ProteinsEscherichia coliSalicylic AcidAnti-Bacterial AgentsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

MarRantimicrobial resistanceeffluxouter membrane proteinsrobvirulence

Substanzen

Escherichia coli ProteinsBacterial ProteinsSalicylic AcidAnti-Infective AgentsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Microbiology, University of Manitoba, Winnipeg, MB, Canada.

ORCID-Profile: Ellen M E Sykes, Ayush Kumar

Förderung

  • Natural Sciences and Engineering Research Council of Canada

Zitieren

APA

Sykes, E. M. E., White, D., McLaughlin, S., & Kumar, A. (2024). Salicylic acids and pathogenic bacteria: new perspectives on an old compound. Canadian Journal of Microbiology, 70(1), 1-14. https://doi.org/10.1139/cjm-2023-0123

Vancouver

Sykes EME, White D, McLaughlin S, Kumar A. Salicylic acids and pathogenic bacteria: new perspectives on an old compound. Canadian Journal of Microbiology. 2024;70(1):1-14. doi:10.1139/cjm-2023-0123

BibTeX
@article{Sykes2024,
  author = {Sykes, Ellen M E and White, Dawn and McLaughlin, Sydney and Kumar, Ayush},
  title = {Salicylic acids and pathogenic bacteria: new perspectives on an old compound},
  journal = {Canadian Journal of Microbiology},
  year = {2024},
  volume = {70},
  number = {1},
  pages = {1--14},
  doi = {10.1139/cjm-2023-0123}
}
Kostenlos starten →